Neuren Pharmaceuticals Ltd Total Liabilities

Latest as of June 2025: AU$7.98 Million AUD ≈ $5.64 Million USD

Neuren Pharmaceuticals Ltd total liabilities. Based on the latest financial reports, Neuren Pharmaceuticals Ltd (NEU) has total liabilities worth AU$7.98 Million AUD (≈ $5.64 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NEU asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Neuren Pharmaceuticals Ltd (2000–2024)

Total liabilities of Neuren Pharmaceuticals Ltd from 2000 to 2024. This chart illustrates how Neuren Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Neuren Pharmaceuticals Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Neuren Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Neuren Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Diversified Healthcare Trust NASDAQ:DHC	USA	$2.66 Billion
Changzhou NRB Corp SHE:002708	China	CN¥2.03 Billion
PG Electroplast Limited NSE:PGEL	India	Rs-30.49 Billion
Ziraat Gayrimenkul Yatirim Ortakligi AS IS:ZRGYO	Turkey	TL21.59 Billion
Marqeta Inc NASDAQ:MQ	USA	$676.67K
RLJ Lodging Trust NYSE:RLJ	USA	$3.07 Billion
Mirae Asset Life Insurance Co Ltd KO:085620	Korea	₩30.73 Trillion
Solvac S.A. BR:SOLV	Belgium	€215.41 Million

Liability Composition Analysis (2000–2024)

This chart breaks down Neuren Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NEU total asset value.

Liquidity & Leverage Metrics

Neuren Pharmaceuticals Ltd Total Liabilities Ratios Explained

Neuren Pharmaceuticals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	40.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.75	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuren Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuren Pharmaceuticals Ltd (2000–2024)

The table below shows the annual total liabilities of Neuren Pharmaceuticals Ltd from 2000 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$45.80 Million ≈ $32.41 Million	+7.11%
2023-12-31	AU$42.76 Million ≈ $30.26 Million	+2448.45%
2022-12-31	AU$1.68 Million ≈ $1.19 Million	+108.97%
2021-12-31	AU$803.00K ≈ $568.17K	+6.64%
2020-12-31	AU$753.00K ≈ $532.80K	+34.70%
2019-12-31	AU$559.00K ≈ $395.53K	-71.67%
2018-12-31	AU$1.97 Million ≈ $1.40 Million	+24.87%
2017-12-31	AU$1.58 Million ≈ $1.12 Million	-22.05%
2016-12-31	AU$2.03 Million ≈ $1.43 Million	-18.98%
2015-12-31	AU$2.50 Million ≈ $1.77 Million	-17.37%
2014-12-31	AU$3.03 Million ≈ $2.14 Million	+47.13%
2013-12-31	AU$2.06 Million ≈ $1.46 Million	-3.89%
2012-12-31	AU$2.14 Million ≈ $1.52 Million	+27.20%
2011-12-31	AU$1.68 Million ≈ $1.19 Million	-22.90%
2010-12-31	AU$2.18 Million ≈ $1.55 Million	-25.64%
2009-12-31	AU$2.94 Million ≈ $2.08 Million	-1.19%
2008-12-31	AU$2.97 Million ≈ $2.10 Million	-57.76%
2007-12-31	AU$7.04 Million ≈ $4.98 Million	+108.31%
2006-12-31	AU$3.38 Million ≈ $2.39 Million	+10.88%
2005-12-31	AU$3.05 Million ≈ $2.16 Million	-27.41%
2004-12-31	AU$4.20 Million ≈ $2.97 Million	-72.78%
2003-12-31	AU$15.41 Million ≈ $10.91 Million	+921.40%
2002-12-31	AU$1.51 Million ≈ $1.07 Million	-91.01%
2001-12-31	AU$16.78 Million ≈ $11.87 Million	+120.34%
2000-12-31	AU$7.62 Million ≈ $5.39 Million	--

About Neuren Pharmaceuticals Ltd

AU:NEU Australia Biotechnology

Market Cap

$2.08 Billion

AU$2.94 Billion AUD

Market Cap Rank

#6515 Global

#160 in Australia

Share Price

AU$23.24

Change (1 day)

+17.49%

52-Week Range

AU$11.28 - AU$23.64

All Time High

AU$25.11